PRA_StandardLogo_RGB_Pink.png
PRA’s Center for Rare Diseases Launches Toolkit to Identify and Mitigate Risks to Rare Disease Clinical Programs
22 mars 2021 16h01 HE | PRA Health Sciences, Inc.
RALEIGH, N.C., March 22, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today the launch of its Patient-Centric Trial Development Toolkit, available now to clinical...
PRA_StandardLogo_RGB_Pink.png
PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2020 Results
24 févr. 2021 06h04 HE | PRA Health Sciences, Inc.
Net new business of $872.4 million in the fourth quarter excluding reimbursement revenue; representing growth of 32.4%; Net book-to-bill of 1.42Net new business of $1,437.8 million in the fourth...
PRA_StandardLogo_RGB_Pink.png
PRA Health Sciences to Report Fourth Quarter and Full Year 2020 Earnings
04 févr. 2021 13h01 HE | PRA Health Sciences, Inc.
RALEIGH, N.C., Feb. 04, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its fourth quarter and full year 2020 results after the market closes on Thursday, February 25,...
PRA_StandardLogo_RGB_Pink.png
PRA Health Sciences collaborates with PWNHealth and Fulgent Genetics to provide at-home COVID-19 test capabilities
17 déc. 2020 16h02 HE | PRA Health Sciences, Inc.
RALEIGH, N.C., Dec. 17, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today the enhancement of its COVID-19 Monitoring Program with the addition of at-home COVID-19 testing...
PRA_StandardLogo_RGB_Pink.png
PRA Health Sciences任命FDA高级官员领导新的去中心化临床试验战略全球卓越中心
23 nov. 2020 14h28 HE | PRA Health Sciences, Inc.
北卡罗来纳州罗利市, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc.(NASDAQ:PRAH)今天宣布任命Isaac...
PRA_StandardLogo_RGB_Pink.png
PRA Health Sciences nombra alto funcionario de la FDA para liderar el nuevo Centro Global de Excelencia para la Estrategia de Ensayos Clínicos Descentralizados
23 nov. 2020 14h28 HE | PRA Health Sciences, Inc.
RALEIGH, CAROLINA DEL NORTE, Nov. 23, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) anunció hoy el nombramiento del Dr. Isaac Rodríguez-Chávez, PhD, MHS, MS, como vicepresidente...
PRA_StandardLogo_RGB_Pink.png
PRA Health Sciences nomeia alto funcionário da FDA para liderar o novo Centro Global de Excelência da Estratégia de Testes Clínicos Descentralizados
23 nov. 2020 14h28 HE | PRA Health Sciences, Inc.
RALEIGH, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- A PRA Health Sciences, Inc. (NASDAQ: PRAH) anunciou hoje a nomeação de Isaac Rodriguez-Chávez, PhD, MHS, MS, como Vice-Presidente Sênior, Assuntos...
PRA_StandardLogo_RGB_Pink.png
PRA Health Sciences melantik pegawai kanan FDA untuk mengetuai Pusat Kecemerlangan Global untuk Strategi Kajian Klinikal Terpencar
23 nov. 2020 14h28 HE | PRA Health Sciences, Inc.
RALEIGH, N.C., Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) hari ini mengumumkan pelantikan Isaac Rodriguez-Chavez, PhD, MHS, MS sebagai Timbalan Presiden Kanan, Hal...
PRA_StandardLogo_RGB_Pink.png
PRAヘルスサイエンス、FDAシニアオフィサーを分散型臨床試験戦略のグローバル・センター・オブ・エクセレンス統括者に任命
23 nov. 2020 14h28 HE | PRA Health Sciences, Inc.
ノースカロライナ州ローリー発, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRAヘルスサイエンス (PRA Health Sciences, Inc.、NASDAQ: PRAH) は本日、アイザック・ロドリゲス・チャベス (Isaac Rodriguez-Chavez) 博士 (保健学修士、理学修士)...
PRA_StandardLogo_RGB_Pink.png
PRA Health Sciences nomme un haut responsable de la FDA pour diriger le nouveau Centre mondial d'excellence pour la stratégie d'essais cliniques décentralisés
23 nov. 2020 14h28 HE | PRA Health Sciences, Inc.
RALEIGH, Caroline du Nord, 23 nov. 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ : PRAH) a annoncé aujourd'hui la nomination d'Isaac Rodriguez-Chavez, PhD, MHS, MME, au poste de...